Improved Glycemic Control due to Reduction in Glucagon Levels by the Administration of Once-Weekly Dulaglutide in a Non-Obese Patient With Type 2 Diabetes

Shingo Morimitsu, Hidetaka Hamasaki
  • Journal of Endocrinology and Metabolism, January 2018, Elmer Press, Inc.
  • DOI: 10.14740/jem486w

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.14740/jem486w

The following have contributed to this page: Hidetaka Hamasaki